WLNC & iCure Stroke 2024
May | 2024
As Acandis GmbH we are proud to be in Istanbul for the World Live Neurovascular Conference and iCure Stroke launching our HEAL Technology.
AMAZT Magdeburg
April | 2024
This week we hosted an aneurysm workshop for advanced physicians at the Forschungscampus STIMULATE in Magdeburg.
HEAL Technology Meeting
February | 2024
In February, we invited physicians from all over Germany to the 1st “Acandis HEAL Technology Meeting” in Leipzig to experience a day full of scientific presentations, lively discussions and sharing of previous experiences.
abc-win
January | 2024
The conference has been held in the French Alps since 1980 and is one of the most renowned meetings in the field of neurovascular intervention.
X-Day Pforzheim
December | 2023
On December 19, 2023, the 39th X-Day took place at Pforzheim University. Our participation enabled us to give students and graduates an insight into our company and meet potential future employees.
Publication DERIVO 2heal
December | 2023
Goertz, L. et al.
First clinical experience with the Derivo 2heal embolization device for the treatment
of intracranial aneurysms
Interventional Neuroradiology, 2023, 19
DOI: 10.1177/15910199231193577
CREDO Workshop
November | 2023
Another succesful workshop earlier this week in Solingen! In cooperation with MVZ GmbH Solingen, we organise several workshops per year on the therapy of intracranial stenosis with the CREDO® Stent in combination with the NeuroSpeed® PTA Balloon Catheter.
Learn more >
Acandis Octoberfest
October | 2023
In October, we celebrated our traditional Octoberfest at the “Wedding Ranch” in Pforzheim. With pleasant temperatures, we enjoyed a party with Bavarian specialities and Octoberfest hits. To reinforce the motto, the “High Striker” was one of the highlights in the evening. Together we celebrated further successes and milestones of the year.
Press Release
October | 2023
We would like to call your attention to some corrections to the article: “Surface modification of neurovascular stents: from bench to patient” (Zoppo et al. 2023) which addresses, among other things, characteristics of the fibrin-heparin coating
(HEAL Technology).
